Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/oxford-university-press/improving-access-to-essential-medicines-how-health-concerns-can-be-fN05q0TwPB
References (13)
-
India is of course unique as it has a large population and economic independence from donor countries -
John Odell (2006)
Negotiating trade : developing countries in the WTO and NAFTA -
http://www.iprcommission.org/graphic/Views articles/GlaxoSmithKline.htm References -
Thomas Pogge (2006)
Montréal Statement on the Human Right to Essential MedicinesCambridge Quarterly of Healthcare Ethics, 16
-
Mayur Patel (2007)
New Faces in the Green Room: Developing Country Coalitions and Decision-Making in the WTO -
(2006)
Doha + Five: The Doha Declaration on the TRIPS Agreement and Public Health, after Five Years -
(2002)
This analysis draws on the important work of Mayur Patel -
Michael Ravvin (2008)
Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed SolutionsPublic Health Ethics, 1
-
A. Attaran (2004)
How do patents and economic policies affect access to essential medicines in developing countries?Health affairs, 23 3
-
Kelley Lee, D. Sridhar, Mayur Patel (2009)
Bridging the divide: global governance of trade and healthLancet (London, England), 373
-
C. Thomas (2002)
Trade policy and the politics of access to drugsThird World Quarterly, 23
-
John Odell, Susan Sell (2006)
Negotiating Trade: Reframing the issue: the WTO coalition on intellectual property and public health, 2001 -
H. Murphy (2010)
Safeguards Pending: TRIPS and the Access to Medicines Campaign
- Publisher
- Oxford University Press
- Copyright
- The Author 2008. Published by Oxford University Press. Available online at www.phe.oxfordjournals.org
- Subject
- Original Article
- ISSN
- 1754-9973
- eISSN
- 1754-9981
- DOI
- 10.1093/phe/phn012
- Publisher site
- See Article on Publisher Site
Abstract
This paper discusses the politics of access to essential medicines and identifies space in the current system where health concerns can be strengthened relative to trade. This issue is addressed from a global governance perspective focusing on the main actors who can have the greatest impact. These include developing country coalitions and citizens in developed countries though participation in civil society organisations. These actors have combined forces to tackle this issue successfully, resulting in the 2001 Doha Declaration on Public Health. The collaboration has been so powerful due to the assistance of the media as well as the decision to compromise with pharmaceutical companies and their host countries. To improve access to essential medicines, six C's are needed: coalitions, civil society, citizenship, compromise, communication and collaboration.
Journal
Public Health Ethics – Oxford University Press
Published: Jul 3, 2008